A prospective study comparison of the mobile medical game, OdySight, with standard clinical eye tests Study concludes that OdySight would be a good alternative for remote monitoring of vision between clinic visits, and could potentially assist in follow-up planning...
CoNextions Medical, a developer of novel soft tissue repair devices, announced today that it has completed enrollment in a key clinical trial for its pioneering tendon-to-tendon repair device, CoNextions TR. Pending successful results of the trial, the company plans...
People allergic to peanuts may have a new way to protect themselves from severe allergic reactions to accidental peanut exposure. It’s called sublingual immunotherapy – or SLIT – and it involves putting a miniscule amount of liquefied peanut protein...
PARP7 is a Novel Tumor Dependency, Enabling Cancer Cells to Evade the Immune System First Ever Clinical Evaluation of a monoPARP Inhibitor Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated...
— MARIO-3 Phase 2 Study to Evaluate Triple Combination Therapy with IPI-549 in the Frontline Setting in Triple Negative Breast Cancer and Renal Cell Cancer — — Phase 1/1b Study with Arcus Biosciences to Evaluate Triple Combination Therapy with...
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today announced results from the Company’s first-in-patient Phase...
Email
Text